- Home
- DRVN vs NEO Comparison
DRVN vs NEO Comparison
Compare DRVN & NEO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | DRVN | NEO |
|---|---|---|
| Founded | 1972 | 2001 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Automotive Aftermarket | Precision Instruments |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.1B | 2.1B |
| IPO Year | 2020 | 2008 |
Fundamental Metrics
Financial Performance| Metric | DRVN | NEO |
|---|---|---|
| Price | $13.22 | $17.56 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 8 | 8 |
| Target Price | ★ $18.33 | $13.38 |
| AVG Volume (30 Days) | 866.4K | ★ 1.6M |
| Earning Date | 05-12-2026 | 04-28-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 146.70 | N/A |
| EPS | ★ 0.54 | N/A |
| Revenue | ★ $1,862,438,000.00 | N/A |
| Revenue This Year | N/A | $10.63 |
| Revenue Next Year | $1.53 | $9.73 |
| P/E Ratio | $25.11 | ★ N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $9.80 | $7.07 |
| 52 Week High | $18.60 | $19.76 |
Technical Indicators
Market Signals| Indicator | DRVN | NEO |
|---|---|---|
| Relative Strength Index (RSI) | 51.37 | 60.12 |
| Support Level | $11.97 | $15.72 |
| Resistance Level | $13.49 | $19.76 |
| Average True Range (ATR) | 0.42 | 0.85 |
| MACD | 0.11 | -0.07 |
| Stochastic Oscillator | 70.38 | 42.86 |
Price Performance
Historical ComparisonAbout DRVN Driven Brands Holdings Inc.
Driven Brands Holdings Inc is an automotive services company in North America. Its platform provides high-quality services to an extensive range of retail and commercial customers. The company provides an extensive range of core consumer and commercial automotive needs, including paint, collision, glass, and repair services, as well as a variety of high-frequency services, such as oil changes and car washes. The company segments; Take 5, Franchise Brands, and Auto Glass Now. It derives maximum revenue from Take 5 Segment. Geographically, the company operates into United States, Canada and Rest of the World.
About NEO NeoGenomics Inc.
NeoGenomics Inc provides oncology diagnostic testing and consultative services which include technical laboratory services and professional interpretation of laboratory test results by licensed physicians or molecular experts in pathology and oncology. The company operates a network of cancer-focused testing laboratories in the United States and the United Kingdom. The company operates in a single segment and derives revenue from clients by providing clinical cancer testing, interpretation, and consultative services, molecular and NGS testing, comprehensive technical and professional services offerings, clinical trials and research, validation laboratory services, and oncology data solutions.